Navigation Links
Replidyne Phase II Pediatric Trial Meets Primary Objective

c patients.

About Acute Otitis Media

Acute otitis media (AOM) is the most frequent pediatric bacterial infection that results in the prescription of an antibiotic and accounts for 30 million office visits in the US annually. Oral antibiotics are the most widely prescribed medicines to treat AOM in children and fall into two primary classes, macrolides and beta-lactams. According to IMS data, beta-lactams represent 88% of all pediatric antibiotic prescriptions for this illness.

About Replidyne, Inc.

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Replidyne's lead product, faropenem medoxomil, is a novel oral, community antibiotic, expected to be appropriate for use as a first-line antibiotic for treatment of respiratory and skin infections in adult and pediatric patients. Replidyne's second drug candidate, REP8839, is a topical anti-infective product under Phase I development for the treatment of skin and wound infections, including methicillin resistant S. aureus (MRSA) infections. Replidyne is also pursuing the development of other novel anti-infective products based on its in-house discovery research.

Safe Harbor

This press release contains plans, intentions, objectives, estimates and expectations that constitute forward-looking statements about Replidyne, Inc. that involve significant risks and uncertainties. Actual results could differ materially from those discussed due to a number of factors including, the success and timing of pre-clinical studies and clinical trials; the Company's ability to obtain and maintain regulatory approval of product candidates and the labeling under any approval that may be obtained; plans to develop and commercialize product candidates; the loss of key scientific or management personnel; the size and growth of the potential markets for the Company's product candidates and the Company's ability
'"/>




Page: 1 2 3

Related medicine technology :

1. Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Replidyne Phase Pediatric Trial Meets Primary Objective
(Date:11/23/2009)...ORK,Nov.23/PRNewswire/--Reportlinker.comannouncest...ue. ,, U.S.MarketforPACSandEMR ,, http:/...and-EMR.html#utm_source=prnewswire&utm_medium=...emarketforPACSwasvaluedatalmost$1.3billion,represe...slargehospitals(500+beds),mediumhospitals(201-499b...
(Date:11/23/2009)...ORK,Nov.23/PRNewswire/--Reportlinker.comannouncest...ue. ,, HolterMonitoringSystems-AGlobalMarketRe.../Holter-Monitoring-Systems---A-Global-Market-Revie...;utm_campaign=prnewswire ,, Cardiovascularm...igh-riskpatientsneedtobecontinuouslymonitoreddurin...
(Date:11/23/2009)...INGHAM,Ala.andNOIDA,India,Nov.23/PRNewswire-USNews...irmingham(UAB),andSouthernResearchInstitutetodayan...collectiveinnovationandenablingtechnologiesinthear...s.ItisauniqueU.S.-Indiaarbitragedandleveragedpartn...therapiesforpatientsworldwide.AMemorandumofUnderst...
Breaking Medicine Technology:Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Recovering with 4 legged friends requires less pain medication 61443 1Recovering with 4 legged friends requires less pain medication 61443 2Penguins and sea lions help produce new atlas 10744 1Penguins and sea lions help produce new atlas 10744 2ASU research efforts to improve human health will get 243 million in federal stimulus grants 10739 1ASU research efforts to improve human health will get 243 million in federal stimulus grants 10739 2ASU research efforts to improve human health will get 243 million in federal stimulus grants 10739 3
... Scientific Meeting, SOUTH SAN FRANCISCO, Calif., ...ay announced that Yonchu,Jenkins, Ph.D., Associate...ompany,s efforts to develop a small molecule thera...ciency Virus (HIV),infection at the Keystone Sympo...r. Jenkins will present both a poster and an oral,...
...ursday, March 29, 2007,At 2:00 p.m. Pacific Time ...diciNova, Inc.,a biopharmaceutical company that i...daq:MNOV) and the Hercules Market of the Osaka,Sec...ed positive,clinical findings from the 12-month co...hat measures both surrogate,(radiological) and cli...
Other Medicine Technology:Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 2MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 3MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 4MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 5
(Date:11/23/2009)... ,, CHERRYHILL,N.J.,Nov.23/PRNewswire/--Inas...iveOfficersandChiefFinancialOfficers,72percentdono...erhealthcaresystem. ,, Accordingtoresultsofthel...erryHill,NJaccountingfirm,theeconomytoppedthelista...esents129responsestoits1500surveyssenttocompaniesf...
(Date:11/23/2009)... Obstructive polyps can impair breathing, protein...ealthDay News) -- U.S. researchers say they,ve id...lyps in 15 percent to 30 percent of people with c... most serious forms of sinusitis, a constant irrit... unhealthy overgrowths of sinus tissue -- can bloc...
(Date:11/23/2009)... , , ARLINGTON, Va. The Infectious Diseases Soc...from the Obama administration and the European Uni... development of 10 new antibiotics within the next...World Health Organization (WHO) has identified ant... threats to human health. , A new European Union...
(Date:11/23/2009)... , Plastic and Reconstruc... designed to keep you updated on the most current ...Surgeons. To obtain any of the full studies highli...esperson, please contact ASPS Public Relations at ... (Vocus) November 23, 2009 -- ...
(Date:11/23/2009)... ,, HARRISBURG,Pa.,Nov.23/PRNewswire/--Unite...rers,todaylauncheditsnewlyredesignedWebsite,www.un...rmationformembers,producers,employersanddentists. ...nandimprovednavigation,allgearedtowardhelpingvisit...UnitedConcordiaDental,se-commerceprojectdirector."...
Breaking Medicine News(10 mins):Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3
...co-related cancer increase in Mizoram, which happe...cording to authorities, Mizoram has the highest in... Tobacco is being used in various forms incl... among children and women. Tobacco is sold...
...umours may rely on a new, non-surgical procedure c...ready been successful in treating Hollywood talent...ith a malignant tumour in his left kidney. ... both of which can have complications and result i...
...med that the popularity of cashmere, which is che...t more and more people are experiencing trouble wi...was quoted by Scotsman as saying that the number o.... There is a real problem which appears to have be...
...mmonly prescribed antidepressants may be linked to...omen . The antidepressant medications know...s) treat depression by inhibiting the protein that...y been discovered in bone as well. The fin...
...at Washington University School of Medicine has di...ease that affects about three per cent of children...Journal of Human Genetics, is significant because ...thought to play a critical role in many basic func...
...ley and her co-star Sienna Miller are enjoying her...ge Of Love' . 'The Pirates of the Caribbea...r times a day to beef up for her role in the film....have bigger appetites than most of the men on the ...
Other Medicine News:Health News:Concern in Mizoram Over Growing Tobacco-related Diseases 2Health News:Radio-frequency Ablation Offers Hope for People With Inoperable Kidney Tumours 2Health News:Brits Experiencing Moth Trouble With Their Cashmeres 2Health News:Common Antidepressants Linked to Increased Bone Loss in Older Adults 2Health News:Common Antidepressants Linked to Increased Bone Loss in Older Adults 3Health News:First Gene Linked to Scoliosis Identified 2
Polymax
Sononav Intraoperative Imaging System
...the two steps are performed in sequence automatica...use disposable cartridge and placed in the dual ac... the cycle begins. The platelet plasma is separate...p concentrates fibrinogen, platelets and all other...
Syringe Avitene
Medicine Products: